13 results
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
22 Jun 23
Globestar Therapeutics Enters into Mou with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
5:18pm
Therapeutics
GlobeStar Therapeutics Corporation (OTC PINK:GSTC) (GSTC)’s mission is to pioneer biotechnology in transformative therapies for the management
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
12 Oct 21
Regulation FD Disclosure
8:27am
, and treatments for disease. With a mission to “help people begin their journeys to health,” GlobeStar Therapeutics also brings high quality supplement
8-K
GSTC
GlobeStar Therapeutics Corp
4 Oct 21
Regulation FD Disclosure
8:48am
for Multiple Sclerosis. Attached is updated Multiple Sclerosis drug development information and our mission – our technology.
Item 9.01 Financial
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
4 Oct 21
Regulation FD Disclosure
8:48am
, development, and treatments for disease. With a mission to “help people begin their journeys to health,” GlobeStar Therapeutics also brings high quality
8-K
GSTC
GlobeStar Therapeutics Corp
20 Sep 21
Multiple Sclerosis Drug Development Information September 2021
8:16am
information and our mission – our technology.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Multiple Sclerosis Drug Development
8-K
EX-99
107mth yj86s2isg02
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
fnp09m6k8mp
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
2sx8d84h2q
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
zjz78zlaw442eqsp1b
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
1bkjb9urb 3wth6e
16 Apr 21
AngioSoma, Inc. Is Pleased to Welcome William Farley to Its Board of Directors
4:20pm
8-K
lnofeut
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
8-K
2ufc5qegtu9hx9s2h
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
8-K
EX-99
gvs5rxuoriwl3nh1vk
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
- Prev
- 1
- Next